GNH USA

Europe — EMA

Ozawade (Pitolisant)

Pitolisant, the active ingredient in Ozawade, is a histamine H3 receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of excessive daytime sleepiness in adults with narcolepsy.

Request sourcing

1
Pack/s

What is Pitolisant?

Pitolisant, the active ingredient in Ozawade, is a histamine H3 receptor antagonist presented as a tablet for oral use. It is indicated for the treatment of excessive daytime sleepiness in adults with narcolepsy. GNH USA supplies Ozawade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Ozawade as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Pitolisant used for?

Ozawade (pitolisant) acts on the histamine H3 receptor pathway to improve wakefulness in sleep‑related disorders.

- Narcolepsy: Reduces daytime sleepiness and improves alertness. - Shift‑work sleep disorder: Helps regulate sleepiness during atypical work hours. - Obstructive sleep apnea (treated ​as ​adjunct ​therapy): May reduce residual sleepiness when used with standard therapy.

What are the side effects of Pitolisant?

Pitolisda  ...

What precautions apply to Pitolisant?

...

What does Pitolisant interact with?

{"type":"Drug","name:":{}}

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Pitolisant
Route
Oral Use
Manufacturer
Bioprojet Pharma
Origin
EU

Related products